Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

The hair fiber filler product increased satisfaction and improved quality of life for people with thinning hair.

Certain proteins might predict surgical success in trigeminal neuralgia treatment.

Dermatology residents need thorough training in dermatosurgery for better patient outcomes.

Patients and doctors often disagree on alopecia areata severity and treatment satisfaction.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

Fractional CO2 laser is more effective and safer than steroid injections for treating alopecia areata.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Customizing non-invasive treatments for head and neck neuralgia improves patient outcomes.

Removing certain muscles during a browlift reduces glabellar wrinkles better long-term.

Most patients stop using topical minoxidil due to side effects.

Platelet-rich plasma is a safe and effective treatment for hair loss with high patient satisfaction.

New methods for skin and nerve regeneration can improve healing and feeling after burns.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

Many people with skin conditions don't seek professional help, often due to self-management beliefs.

Lichen Sclerosus causes itching, pain, and potential complications in the genital area.

Endoscopy-assisted surgery for craniosynostosis showed excellent outcomes with minimal complications and most patients went home the day after surgery.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

AI can help track and improve hair loss treatment outcomes.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Early diagnosis and treatment of achalasia and hyperthyroidism improve patient outcomes.

AI improves medical care by enhancing diagnosis and treatment for better patient outcomes.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

The guideline helps diagnose and treat hidradenitis suppurativa early to improve patient outcomes.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.